Effect of IL-10 in the pathogenesis of HIV/AIDS patients with cryptococcal meningitis

被引:0
|
作者
Lida Mo
Guosheng Su
Hanzhen Su
Wanhong Huang
Xiaolu Luo
Chuanmin Tao
机构
[1] Nanning Infectious Disease Hospital Affiliated to Guangxi Medical University,Department of Laboratory Medicine, Nanning Fourth People’s Hospital, Guangxi AIDS Clinical Treatment Center (Nanning)
[2] Sichuan University,Department of Laboratory Medicine, West China Hospital
[3] The Tenth People’s Hospital of Nanning,Department of Laboratory Medicine, People’s Hospital of Guangxi
来源
Molecular and Cellular Biochemistry | 2023年 / 478卷
关键词
Pathogenesis; IL-10; Cryptococcal meningitis (CM); HIV/AIDS;
D O I
暂无
中图分类号
学科分类号
摘要
This study aimed to explore the role of IL-10 in the pathogenesis of HIV/AIDS patients with cryptococcal meningitis (CM).Patients were assigned into 4 groups (n = 40/group): group A (HIV/AIDS with CM), group B (HIV/AIDS with tuberculosis), group C (HIV/AIDS), and group D (CM). The levels of IL-10 and associated indicators were measured and the correlations were analyzed by Pearson correlation and partial correlation method. In plasma and cerebrospinal fluid (CSF), no significant difference was observed on IL-10 level between group A and other groups (P > 0.050). R values for IL-10 and relevant indicators in blood were as follows (P < 0.050): group A, IFN-γ (−0.377), IL-12 (0.743), IL-4 (0.881), and IL-6 (0.843); group B, IL-12 (0.740), IL-4 (0.573), and IL-6 (0.900); group C, IL-12 (0.402) and IL-4 (0.896); group D, IL-12 (0.575), IL-4 (0.852), and CD8 (0.325). R values for IL-10 and related indicators in CSF were as follows (P < 0.050): group A, TNF-α (0.664), IL-4 (0.852), white blood cells (WBCs, 0.321) and total protein (TP, 0.330); group B, TNF-α (0.566), IL-4 (0.702), and lactate dehydrogenase (LDH, 0.382); group D, IFN-γ (0.807) and IL-4 (0.441). IL-10 level was positively correlated with IL-4, IL-6, IL-12, TNF-α, WBC, and TP in blood or CSF, and negatively correlated with IFN-γ in blood, suggesting that IL-10 affected both pro-inflammatory and anti-inflammatory activities in the pathogenesis of HIV/AIDS with CM.
引用
收藏
页码:1 / 11
页数:10
相关论文
共 50 条
  • [22] Polymorphisms of CCR5, IL-6, IFN-γ and IL-10 genes in Cuban HIV/AIDS patients
    Requejoa, D. Hernandez
    de Armasb, Y.
    Iglesiasd, E.
    Diaz, H. M.
    Gravierf, R.
    Lopez, M. C. Godinez
    Fonteg, L.
    Plascencia-Cruzh, M.
    Pacheco-Quijanoh, K.
    Palomaresh, J.
    Perez-Gomez, H. R.
    Plascencia-Hernandez, A.
    Calderon, E. J.
    REVISTA CLINICA ESPANOLA, 2024, 224 (02): : 96 - 104
  • [23] FLUCONAZOLE COMBINED WITH FLUCYTOSINE FOR TREATMENT OF CRYPTOCOCCAL MENINGITIS IN PATIENTS WITH AIDS
    LARSEN, RA
    BOZZETTE, SA
    JONES, BE
    HAGHIGHAT, D
    LEAL, MA
    FORTHAL, D
    BAUER, M
    TILLES, JG
    MCCUTCHAN, JA
    LEEDOM, JM
    CLINICAL INFECTIOUS DISEASES, 1994, 19 (04) : 741 - 745
  • [24] Role of IL-10 in the pathogenesis of dengue infections
    Malavige, G. N.
    Jeewandara, C.
    Alles, L.
    Gomes, L.
    Salimi, M.
    Jayaratne, S. D.
    Ogg, G. S.
    ALLERGY, 2013, 68 : 339 - 339
  • [25] Cryptococcal meningitis in non-HIV-infected patients
    Shih, CC
    Chen, YC
    Chang, SC
    Luh, KT
    Hsieh, WC
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 2000, 93 (04): : 245 - 251
  • [26] Cryptococcal meningitis in AIDS patients: an emerging opportunistic infection in Senegal
    Hovette, P
    Soko, TO
    Raphenon, G
    Camara, P
    Burgel, PR
    Garraud, O
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1999, 93 (04) : 368 - 368
  • [27] Polysaccharide antigen in brain tissue of AIDS patients with cryptococcal meningitis
    Lee, SC
    Casadevall, A
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (01) : 194 - 195
  • [29] Diagnosing of cryptococcal meningitis in AIDS patients by conventional and PCR methods
    Chaiprasert, A
    Munsrishoom, A
    Prariyachatigul, C
    Tansuphaswadikul, S
    TRENDS IN MEDICAL MYCOLOGY, 2003, : 91 - 98
  • [30] Cryptococcal meningitis: Current approaches to management in patients with and without AIDS
    Brizendine K.D.
    Pappas P.G.
    Current Infectious Disease Reports, 2010, 12 (4) : 299 - 305